Exploring the Anticancer Activity of Gold Complex with Newly Ligand (DDIBM): Synthesis, Spectral Identification and Magnetic Susceptibility of Its Metallic Complexes

Siham Sami Noor; Ibtihal Kadhim Kareem

doi:10.22146/ijc.89954

Exploring the Anticancer Activity of Gold Complex with Newly Ligand (DDIBM): Synthesis, Spectral Identification and Magnetic Susceptibility of Its Metallic Complexes

https://doi.org/10.22146/ijc.89954

Siham Sami Noor⁽¹⁾, Ibtihal Kadhim Kareem^(2*)

(1) Department of Chemistry, Faculty of Education for Girls, Kufa University, Najaf 54001, Iraq
(2) Department of Chemistry, Faculty of Education for Girls, Kufa University, Najaf 54001, Iraq
(*) Corresponding Author

Abstract

The new heterocyclic ligand, 5-(dimethylamino)-2-(((2-((E)-(4,5-diphenyl-1H-imidazol-2-yl)diazenyl)benzyl)imino)methyl)phenol (DDIBM), was synthesized via the condensation of p-aminobenzylamine with 4,5-diphenyl imidazole, and the resultant compound was condensed with 4-(dimethylamino)-2-hydroxybenzaldehyde. Various instrumental techniques such as mass, ¹H-NMR, IR, C.H.N elemental analysis, and UV-vis spectroscopy were used to analyze a newly synthesized ligand. A novel series of complexes was prepared by complexing the ligand with Ni(II), Cu(II), Co(II), and Au(III) and characterized using some of the mentioned techniques. Flame atomic absorption spectroscopy was used to measure the metal ion percentages in the complexes. The magnetic susceptibility and molar conductivity were studied. The electronic spectral data and the magnetic measurement predict the octahedral structure of the complexes except Au(III) complex which has square planer geometry. All complexes showed electrolyte properties. This study aimed to conduct an in vitro cytotoxicity comparative study of DDIBM and its Au(III) complex on human breast cancer cells (MCF-7) and other normal cells. The Au(III) complex was found to be highly selective in targeting cancer cells without affecting normal healthy cells, compared to the ligand. Thus, this complex can be considered as a new drug for treating breast cancer cells (MCF-7), and an attempt in the future to study its effect on other types of cancer.

Keywords

azo–imine ligand; breast cancer; metallic complexes; ortho-amino benzylamine derivatives

Full Text:

Full Text PDF Full Text PDF-Suppl. Data

References

[1] Imran, W.J., Kareem, I.K., and Jaafar, R.R., 2023, Synthesis and spectral identifications of new azo–Schiff base ligand (4Cl-2DIBP) derived from (para-aminobenzylamine) with its some metallic complexes, J. Kufa Chem. Sci., 2 (10), 2–16.

[2] Kadhim, A.A., Kareem, I.K., and Ali, A.A.M., 2022, Synthesis and spectral identification of new azo-Schiff base ligand derivative from aminobenzylamine and its novel metal complexes with Cu(II), Zn(II) and Hg(II), Int. J. Drug Delivery Technol., 12 (1), 1–7.

[3] Imran, W.J., and Kareem, I.K., 2022, Synthesis, characterization of some metallic complexes with new azo–Schiff base ligand derived from (para-aminobenzylamine) and a study of the anticancer activity (MCF-7) of the new ligand and its complex with Zn(II), HIV Nurs., 22 (2), 2745–2753.

[4] Valarmathy, G., Subbalakshmi, R., Rengathan, R., and Kokila, R., 2018, Synthesis of Schiff base (E)-2-(((3-hydroxyphenyl)imino)methyl)-6-methoxyphenol containing N and O donors and its metal complexes: Spectral, thermal, redox behavior, fluorescence quenching, antimicrobial, and anticancer studies, Asian J. Chem., 30 (3), 645–650.

[5] El-Gammal, O.A., El-Bindary, A.A., Sh. Mohamed, F., Rezk, G.N., and El-Bindary, M.A., 2021, Synthesis, characterization, design, molecular docking, anti-COVID-19 activity, DFT calculations of novel Schiff base with some transition metal complexes, J. Mol. Liq., 346, 117850.

[6] Zhang, Z., Song, Q., Jin, Y., Feng, Y., Li, J., and Zhang, K., 2023, Advances in Schiff base and its coating on metal biomaterials-A review, Metals, 13 (2), 386.

[7] Baper, S.H., and Mohammd, M.S., 2022, Synthesis, characterization, and study anticancer activity of new azo–chalcone with mix ligand of some divalent metal chelate complexes, J. Kufa Chem. Sci., 2 (9), 390–408.

[8] Kunitake, F., Kim, J.Y., Yagi, S., Yamzaki, Y., Haraguchi, T., and Akitsu, T., 2019, Chiral recognition of azo-Schiff base ligands, their Cu(II) complexes, and their docking to laccase as mediators, Symmetry, 11 (5), 666.

[9] Ali, S.A., Elzawi, N.R., and Elyassiry, A.M., 2021, Synergistic and antagonistic effects of azo-Schiff base with some antibiotics on gram-positive bacterial isolates, Res. Rev.: J. Microbiol. Virol., 11 (2), 25–31.

[10] Hadi, M.A., and Kareem, I.K., 2020, Synthesis, characterization and spectral studies of a new azo-Schiff base ligand derived from 3,4-diamino benzophenone and its complexes with selected metal ions, Res. J. Adv. Sci., 1 (1), 54–73.

[11] Al-Adilee, K.J., and Hasan, S.R., 2021, Synthesis, characterization and biological activity of heterocyclic azo-Schiff base ligand derived from 2-amino-5-methyl thiazol and some transition metal ions, IOP Conf. Ser.: Earth Environ. Sci., 790 (1), 012031.

[12] Ashoor, L.S., Majeed, R.A., and Al-Shemary, R.K.R., 2021, Applications of biological of azo-Schiff base ligand and its metal complexes and: A review, Muthanna J. Pure Sci., 8 (1), 74–90.

[13] Jasim, E.Q., Alasadi, E.A., Fayadh, R.H., and Muhamman-Ali, M.A., 2020, Synthesis and antibacterial evaluation of some azo-Schiff base ligands and estimation the cadmium metal by complexation, Syst. Rev. Pharm., 11 (6), 677–687.

[14] Taha, N.I., Tapabashi, N.O., and El-Subeyhi, M.N., 2018, Green synthesis of new tetra Schiff bases and bis-azo bis-Schiff bases derived from 2,6-diaminopyridine as promising photosensitizers, Int. J. Org. Chem., 8 (3), 309–318.

[15] Ispir, E., Ikiz, M., Inan, A., Sünbül, A.B., Tayhan, S.E., Bilgin, S., Köse, M., and Elmastaş, M., 2019, Synthesis, structural characterization, electrochemical, photoluminescene, antiproliferative and antioxidant properties of Co(II), Cu(II), and Zn(II) complexes bearing the azo-azomethine ligands, J. Mol. Struct., 1182, 63–71.

[16] Taaima, A.N., and Mohammed, M.S., 2021, Synthesis, characterization and antibacterial activity of mixed ligand derived for vanillin with some transition metals, Ann. Rom. Soc. Cell Biol., 25 (5), 2282–2295.

[17] Merdas, S.M., 2021, Synthesis, characterization and DFT studies of new azo-Schiff base and evaluation as corrosion inhibitor, Ann. Rom. Soc. Cell Biol., 25 (4), 910–928.

[18] Mohammed, K.F., and Hasan, H.A., 2022, Synthesis, chemical and biological activity studies of azo-Schiff base ligand and its metal complexes, Chem. Methodol., 6 (12), 905–913.

[19] Menati, S., Azadbakht, R., Rudbari, H.A., and Bruno, G., 2021, Synthesis and characterization of four new azo-Schiff base and their nickel(II) complexes, Polyhedron, 205, 115296.

[20] Oulmidi, A., Radi, S., Idir, A., Zyad, A., Kabach, I., Nhiri, M., Robeyns, K., Rotaru, A., and Garcia, Y., 2021, Synthesis and cytotoxicity against tumor cells of pincer N-heterocyclic ligands and their transition metal complexes, RSC Adv., 11 (55), 34742–34753.

[21] Abbas, H.H., Al-Luaibi, M.Y., and Al-Assadi, M.J., 2023, New heterocyclic organo-chalcogenide compounds: Synthesis, physicochemical characterization, and evaluation of anticancer activity against breast cancer cells, Indones. J. Chem., 23 (2), 309–320.

[22] Yasir, A.F., and Jamel, H.O., 2023, Synthesis of a new DPTYEAP ligand and its complexes with their assessments on physical properties, antioxidant, and biological potential to treat breast cancer, Indones. J. Chem., 23 (3), 796–808.

[23] Adnan, S., Al-Adilee, K.J., and Abedalrazaq, K.A., 2020, Synthesis, spectral characterization and anticancer studies of novel azo Schiff base and its complexes with Ag(I), Au(lll) and Pt(lV) ions, Egypt. J. Chem., 63 (12), 4749–4756.

[24] Slassi, S., El-Ghayoury, A., Aarjane, M., Yamni, K., and Amine, A., 2020, New copper(II) and zinc(II) complexes based on azo Schiff base ligand: Synthesis, crystal structure, photoisomerization study and antibacterial activity, Appl. Organomet. Chem., 34 (3), e5503.

[25] Kadhim, A.A., Kareem, I.K., and Ali, A.M., 2021, Synthesis and spectral identification of new azo-Schiff base ligand derivative from aminobenzylamine and its novel metal complexes with Cu(II), Zn(II) and Hg(II), Ann. Rom. Soc. Cell Biol., 25 (6), 4596–4607.

[26] Al-Shuraify, M.K., Al-Amood, H.K., and Sabah, F.S., 2022, Synthesis and characterization of new 1,3-thiazinane derivatives and study their effect on breast cancer (MCF-7), J. Kufa Chem. Sci., 2 (8), 276–278.

[27] Comşa, S., Cimpean, A.M., and Raica, M., 2015, The story of MCF-7 breast cancer cell line: 40 years of experience in research, Anticancer Res., 35, 3147–3154.

[28] Brown, A.M., Jeltsch, J.M., Robert, M., and Chambon, P., 1984, Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7, Proc. Natl. Acad. Sci. U. S. A., 81 (20), 6344–6348.

[29] Wei, H.C., 2019, Mathematical modeling of tumor growth: The MCF-7 breast cancer cell line, Math. Biosci. Eng., 16 (6), 6512–6535.

[30] Jawad, S.A., and Kareem, I.K., 2022, Synthesis, characterization and biological study of open multi dentate new azo-Schiff ligand and it’s divalent metal ion complexes with copper, zinc and mercury, AIP Conf. Proc., 2386 (1), 030014.

[31] Kareem, I.K., and Hadi, M.A., 2020, Synthesis and characterization of some transition metal complexes with new azo-Schiff base ligand 3,4-bis(((1E,2E)-2-((2-((4-((Z)-(3-hydroxyphenyl)diazenyl)naphthalen-1-yl)amino)ethyl)imino)-1,2-diphenylethylidene)amino)phenyl)(phenyl)methanone, Egypt. J. Chem., 63 (1), 301–313.

[32] Abu-Hashem, A.A., Al-Hussain, S.A., and Zaki, M.E.A., 2021, Design, synthesis and anticancer activity of new polycyclic: Imidazole, thiazine, oxathiine, pyrrolo-quinoxaline and thienotriazolopyrimidine derivatives, Molecules, 26 (7), 2031.

[33] Hadi, M.A., Kareem, I.K., and Atban, A.K., 2021, Synthesis and characterization of novel metal complexes with new Schiff base ligand derived from 6-amino pencillic acid and toxicological studies of its complex with Au(III) on human cells for colon cancer LS-174, Biochem. Cell. Arch., 21, 2477–2488.

[34] Odabasoglu, H.K., Erdogan, T., and Karci, F., 2022, Synthesis & characterization of heterocyclic disazo-azomethine dyes and investigating their molecular docking & dynamics properties on acetylcholine esterase (AChE), heat shock protein (HSP90α), nicotinamide N-methyl transferase (NNMT) and SARS-CoV-2 (2019-nCoV, COVID-19) main protease (M^pro), J. Mol. Struct., 1252, 131974.

[35] Ali, A.M., and Hassani, Z.R., 2020, Preparation and characterization of new azo ligand and some of its chelate complexes, J. Kufa Chem. Sci., 2 (6), 13–23.

[36] Mbarki, F., and Ammari, F., 2021, Chemical modification of commercial and recovered poly(vinyl chloride) with amino groups-adsorption of heavy metals (Cr(III), Pb(II), Cd(II), or Co(II)) by modified PVC polymers, J. Maroc. Chim. Heterocycl., 20 (2), 80–94.

[37] Ali, I., Said, M.H., and Al-Wazn, W., 2021, Preparation, characterization and study of complexes containing beta-lactam group with some transitional elements and their biological activity, Egypt. J. Chem., 64 (10), 5703–5712.

[38] Mohammed, L.A., Hadi, M.A., and Basim, N.A., 2020, Preparation and characterization of some complexes with new (azo-Schiff base) ligand and study of complex as anticancer, Indian J. Forensic Med. Toxicol., 14 (2), 1298–1305.

[39] Nassar, M.Y., Ahmed, I.S., Dessouki, H.A., and Ali, S.S., 2018, Synthesis and characterization of some Schiff base complexes derived from 2,5-dihydroxyacetophenone with transition metal ions and their biological activity, J. Basic Environ. Sci., 5, 60–71.

[40] Pahontu, E.M., Socea, L.I., Barbuceanu, S.F., Ilies, D.C., Badea, M., Olaru, O.T., Gulea, A., Socea, B., and Bratu, O.G., 2018, Synthesis, characterization and toxicity evaluation of Cu(II), Mn(II), Co(II), Ni(II), Pd(II) complexes with ligand derived from hydrazinecarbothioamide, Rev. Chim., 69 (11), 2959–2963.

[41] Yahya, W.I., Mgheed, T.H., and Kadhium, A.J., 2022, Preparation, characterization of some metal complexes of new mixed ligands derived from 5-methyl imidazole and study the biological activity of palladium(II) complex as anticancer, NeuroQuantology, 20 (1), 71–83.

[42] Jailani, A.K., Gowthaman, N.S.K., and Kesavan, M.P., 2020, Synthesis, characterisation and biological evaluation of tyramine derived Schiff base ligand and its transition metal(II) complexes, Karbala Int. J. Mod. Sci., 6 (2), 225–234.

[43] Deshmuck, P., Soni, P.K., Kankoriya, A., Halve, A.K., and Dixit, R., 2015, 4-Amino antipyrine: A significant tool for the synthesis of biologically active Schiff base and metal complexes, Int. J. Pharm. Sci. Rev. Res., 34 (1), 162–170.

[44] Bergamo, A., and Sava, G., 2015, Linking the future of anticancer metal-complexes to the therapy of tumour metastases, Chem. Soc. Rev., 44 (24), 8818–8835.

[45] Jawad, S.F., and Aljamali, N.M., 2021, Preparation, investigation and study of biological applications of tyrosine derivatives against breast cancer cells, NeuroQuantology, 19 (9), 117–125.

DOI: https://doi.org/10.22146/ijc.89954